Angiolymphoid hyperplasia with eosinophilia responded well to dupilumab in two cases
These cases support the type 2 inflammation features of ALHE and underscore the critical role of T cells in the pathogenesis. Moreover, these cases also highlight the promising use of dupilumab or other T-helper cell type 2-mediating therapies in treating ALHE.
Authors
- Yi Jiang (ORCID: https://orcid.org/0000-0001-8170-8761)
- Yang Wang (ORCID: https://orcid.org/0000-0001-7805-2861)
- Yu Xiao (ORCID: https://orcid.org/0000-0001-5668-7241)
- Panpan Shang
Institutions
- Peking University (CN)
- National Clinical Research (US)
- Peking University First Hospital (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2025-04-14
- DOI
- https://doi.org/10.1080/09546634.2025.2485262
- Citations
- 3
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 3.14